ATE152524T1 - Antigene zusammensetzungen aus fragmenten von campylobacter pylori und verfahren zu ihrer herstellung und verwendung - Google Patents

Antigene zusammensetzungen aus fragmenten von campylobacter pylori und verfahren zu ihrer herstellung und verwendung

Info

Publication number
ATE152524T1
ATE152524T1 AT89400464T AT89400464T ATE152524T1 AT E152524 T1 ATE152524 T1 AT E152524T1 AT 89400464 T AT89400464 T AT 89400464T AT 89400464 T AT89400464 T AT 89400464T AT E152524 T1 ATE152524 T1 AT E152524T1
Authority
AT
Austria
Prior art keywords
antigen
campylobacter pylori
occurrence
detecting
antibody complex
Prior art date
Application number
AT89400464T
Other languages
English (en)
Inventor
Martin J Blaser
Original Assignee
Enteric Res Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22566281&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE152524(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Enteric Res Lab Inc filed Critical Enteric Res Lab Inc
Application granted granted Critical
Publication of ATE152524T1 publication Critical patent/ATE152524T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT89400464T 1988-02-18 1989-02-17 Antigene zusammensetzungen aus fragmenten von campylobacter pylori und verfahren zu ihrer herstellung und verwendung ATE152524T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/158,003 US5459041A (en) 1988-02-18 1988-02-18 Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection

Publications (1)

Publication Number Publication Date
ATE152524T1 true ATE152524T1 (de) 1997-05-15

Family

ID=22566281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89400464T ATE152524T1 (de) 1988-02-18 1989-02-17 Antigene zusammensetzungen aus fragmenten von campylobacter pylori und verfahren zu ihrer herstellung und verwendung

Country Status (7)

Country Link
US (1) US5459041A (de)
EP (1) EP0329570B1 (de)
JP (1) JP2738947B2 (de)
AT (1) ATE152524T1 (de)
CA (1) CA1339067C (de)
DE (1) DE68928007T2 (de)
ES (1) ES2100850T3 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
USRE34101E (en) * 1991-03-19 1992-10-13 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of Campylobacter pylori and use for serological detection of Campylobacter pylori infection
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US5262156A (en) * 1991-08-12 1993-11-16 Hycor Biomedical, Inc. Antigenic compositions and their use for the detection of Helicobacter pylori
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
WO1993016723A1 (en) * 1992-02-26 1993-09-02 Vanderbilt University Purified vacuolating toxin from helicobacter pylori and methods to use same
CA2131729C (en) 1992-03-02 2008-02-12 Antonello Covacci Helicobacter pylori proteins useful for vaccines and diagnostics
IT1262895B (it) * 1992-03-02 1996-07-22 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
US6130059A (en) * 1992-03-02 2000-10-10 Covacci; Antonello Helicobacter pylori proteins useful for vaccines and diagnostics
US7141244B1 (en) 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
CA2067603A1 (en) * 1992-04-29 1993-10-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
GB9313437D0 (en) * 1993-06-30 1993-08-11 Smith Andrew W Pathogenicity sequences in helicobacter pylori
KR100333113B1 (ko) * 1993-07-27 2002-11-27 시에스엘 리미티드 헬리코박터피롤리관련위십이지장질환의치료방법
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
AU7482694A (en) * 1993-08-27 1995-03-21 Enteric Research Laboratories, Inc. (campylobacter jejuni) antigens, and methods for their production and use
JP2512898Y2 (ja) * 1993-10-01 1996-10-02 厚一 植村 地下構造物用コンクリ―ト函体
US5780040A (en) * 1994-06-08 1998-07-14 Tufts University School Of Medicine Hospital, Inc. Helicobacter pylori nickel binding protein
GB2290866B (en) * 1994-06-29 1998-10-07 Reckitt & Colmann Prod Ltd Detection of Helicobacter pylori infection using antibodies to carbonic anhydrase
US5897475A (en) * 1994-10-05 1999-04-27 Antex Biologics, Inc. Vaccines comprising enhanced antigenic helicobacter spp.
PL183039B1 (pl) * 1994-10-05 2002-05-31 Antex Biolog Inc Bakteria Helicobacter o wzmocnionych właściwościach antygenowych, szczepionka, sposób testowania potencjalnego środka przeciwbakteryjnego, sposób wykrywania przeciwciał gospodarza, sposób wykrywania bakterii, zestaw do immunologicznych testów diagnostycznych, sposób wytwarzania przeciwciał, sposób pobudzania reakcji odpornościowej
WO1996012965A1 (en) * 1994-10-20 1996-05-02 Genelabs Diagnostics Pte Ltd. Helicobacter pylori diagnostic methods and kits
GB9422991D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Analytical method
GB9502899D0 (en) * 1995-02-15 1995-04-05 Cortecs Ltd Novel antigen
FR2736360B1 (fr) 1995-07-04 1997-09-05 Pasteur Institut Clonage et caracterisation du gene fiba de h.pylori, production de souches aflagellees
WO1997025429A1 (en) * 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
US5716791A (en) * 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5932430A (en) * 1996-05-09 1999-08-03 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5702911A (en) * 1996-08-15 1997-12-30 Chek-Med Systems, Inc. Diagnostic test composition
JP2000505902A (ja) * 1996-12-05 2000-05-16 イデゴ・アーペーエス 生物学的流体中の標的分子をイムノアッセイにより検出するためのセンサー積層体及び多区画流体送達装置
SE9702242D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions V
FR2748478B1 (fr) * 1997-07-01 2001-07-13 Pasteur Merieux Serums Vacc Nouvelle proteine membranaire d'helicobacter pylori
FR2748477B1 (fr) * 1997-07-01 2001-07-13 Pasteur Merieux Serums Vacc Nouvelle proteine membranaire d'helicobacter pylori
JP3869556B2 (ja) * 1998-06-15 2007-01-17 勇 近藤 ヘリコバクター・ピロリ由来抗原及びそれを用いたヘリコバクター・ピロリ感染の診断方法
WO2000079283A1 (en) 1999-06-23 2000-12-28 Cornell Research Foundation, Inc. Dehydration/rehydration of marked liposomes on a test device
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
TWI237695B (en) * 1999-12-14 2005-08-11 Joy Biomedical Corp Helicobacter pylori antigens in blood
TWI222357B (en) 2000-01-11 2004-10-21 Medical & Pharm Ind Tech & Dev Anti-ulcer pharmaceutical composition and the preparation and use thereof
DE10006432A1 (de) * 2000-02-14 2001-08-16 Ganzimmun Inst Fuer Ganzheitli Verfahren zum Nachweis von Helicobacter pylori in Stuhl- und Speichelproben
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
US20030166027A1 (en) * 2002-02-21 2003-09-04 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
ATE382861T1 (de) 2002-05-31 2008-01-15 Cornell Res Foundation Inc Universeller biosensor und verfahren zur verwendung
US7629127B2 (en) * 2005-01-21 2009-12-08 Dexall Biomedical Labs, Inc. Method for the visual detection of specific antibodies by the use of lateral flow assays
JP6795481B2 (ja) 2017-11-07 2020-12-02 日立金属株式会社 絶縁電線
JP6756692B2 (ja) 2017-11-07 2020-09-16 日立金属株式会社 絶縁電線

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422651D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
WO1987001119A1 (en) * 1985-08-16 1987-02-26 Gregory Murray Winn Monoclonal antibodies reactive against campylobacter pyloridis
US4882271A (en) * 1988-03-10 1989-11-21 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
US5108892A (en) * 1989-08-03 1992-04-28 Promega Corporation Method of using a taq dna polymerase without 5'-3'-exonuclease activity

Also Published As

Publication number Publication date
ES2100850T3 (es) 1997-07-01
DE68928007T2 (de) 1997-12-04
DE68928007D1 (de) 1997-06-05
EP0329570A3 (de) 1991-05-22
JPH0235096A (ja) 1990-02-05
EP0329570B1 (de) 1997-05-02
US5459041A (en) 1995-10-17
JP2738947B2 (ja) 1998-04-08
CA1339067C (en) 1997-07-29
EP0329570A2 (de) 1989-08-23

Similar Documents

Publication Publication Date Title
ATE152524T1 (de) Antigene zusammensetzungen aus fragmenten von campylobacter pylori und verfahren zu ihrer herstellung und verwendung
DE3751432D1 (de) Rezeptoren für Immunkomplexe, Verfahren zur ihrer Herstellung und Verfahren zur Prüfung diese benutzend.
DE3485920D1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
JPS6488155A (en) Immunological inspection for detecting antibody against antigen
EP0351248A3 (en) Detection of an antibody and antigen in an immunoassay
DE69032854T2 (de) Verfahren, reagenzien und testkits zum nachweis von subpopulationen biologischer substanzen
PL309211A1 (en) Heterogenous specific bond test used for detection or content determination of a given substance in a sample analysed, method of reducing non-specific bonding in pseudohomogenous tests and testing set for performing immunological test and those employing genetic probe
ES552283A0 (es) Un metodo de deteccion de la presencia de una secuencia polinucleotidica particular en una muestra a ensayar
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
SE8900721D0 (sv) Methods for detection of antibodies to
ATE187251T1 (de) Verfahren zum nachweis der gegenwart einer mykobakterien-spezies und testsatz sowie antikörpes zur verwendung in diesem verfahren
KR870008186A (ko) 면역글로부린 Al(IgAl) 단면 분석에 의한 임질진단방법, 그 시약 및 키트(kit)
ATE403866T1 (de) Verfahren zum nachweis von antikörpern in flüssigen proben
DE68922126D1 (de) Immunometrisches Verfahren zum Nachweis von Lipoprotein-Teilchen, anti-Lp(a) Monoklonale Antikörper und ihre Anwendung zur Diagnose von Atherosklerose.
ATE88571T1 (de) Immunologischer testkit.
EP0028133A3 (de) Verfahren zum Nachweis und zur Mengenbestimmung von Haptenen und Antigenen
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
Levine et al. Fast ELISA for measuring serum antibody responses
ATE278193T1 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
Simor et al. Evaluation of a new latex test and a new enzyme immunoassay for determination of rubella immunity
DE69014087D1 (de) Verfahren zur quantitativen und qualitativen Bestimmung von Antikörpern gegen bakterielle Antigene mittels photometrischer Messung der Agglutination.
ATE14799T1 (de) Verfahren zur feststellung sehr geringer antigen- und antikoerpermengen nach einem agglutinations- hemmungstest.
Pickenhahn et al. Correlation between enterotoxigenicity, tested by different ELISA-techniques, antibiotic resistance patterns and phage groups of Staphylococcus aureus strains

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties